NCT05694819 2026-04-08Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)National Cancer Center Hospital EastPhase 2 Completed57 enrolled
NCT02294461 2025-10-24An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer ParticipantsAstellas Pharma IncPhase 3 Completed395 enrolled 25 charts